JP2007507425A - 胃腸管運動障害を処置するために有用な組成物 - Google Patents

胃腸管運動障害を処置するために有用な組成物 Download PDF

Info

Publication number
JP2007507425A
JP2007507425A JP2006524933A JP2006524933A JP2007507425A JP 2007507425 A JP2007507425 A JP 2007507425A JP 2006524933 A JP2006524933 A JP 2006524933A JP 2006524933 A JP2006524933 A JP 2006524933A JP 2007507425 A JP2007507425 A JP 2007507425A
Authority
JP
Japan
Prior art keywords
group
compound
pharmaceutically acceptable
solvate
hydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006524933A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007507425A5 (https=
Inventor
ランダウ，スティーブン，ビー．
アシュバーン，セオドア，ティー．
Original Assignee
ダイノゲン ファーマシューティカルズ，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ダイノゲン ファーマシューティカルズ，インコーポレイテッド filed Critical ダイノゲン ファーマシューティカルズ，インコーポレイテッド
Publication of JP2007507425A publication Critical patent/JP2007507425A/ja
Publication of JP2007507425A5 publication Critical patent/JP2007507425A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2006524933A 2003-08-29 2004-08-27 胃腸管運動障害を処置するために有用な組成物 Pending JP2007507425A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49920003P 2003-08-29 2003-08-29
US59823504P 2004-08-03 2004-08-03
PCT/US2004/028115 WO2005021040A2 (en) 2003-08-29 2004-08-27 Compositions useful for treating gastrointestinal motility disorders

Publications (2)

Publication Number Publication Date
JP2007507425A true JP2007507425A (ja) 2007-03-29
JP2007507425A5 JP2007507425A5 (https=) 2007-10-18

Family

ID=34278649

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006524933A Pending JP2007507425A (ja) 2003-08-29 2004-08-27 胃腸管運動障害を処置するために有用な組成物

Country Status (10)

Country Link
US (3) US20050059704A1 (https=)
EP (1) EP1663313A2 (https=)
JP (1) JP2007507425A (https=)
KR (1) KR20060118421A (https=)
AU (2) AU2004268641A1 (https=)
BR (1) BRPI0414046A (https=)
CA (1) CA2537182A1 (https=)
IL (1) IL173835A0 (https=)
MX (1) MXPA06002139A (https=)
WO (1) WO2005021040A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010529125A (ja) * 2007-06-07 2010-08-26 ダイノジェン ファーマシューティカルズ， インコーポレイテッド 胃食道逆流疾患の治療に有用な組成物
JP2013144719A (ja) * 2009-07-09 2013-07-25 Raqualia Pharma Inc 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060118421A (ko) * 2003-08-29 2006-11-23 다이노젠 파마세우티컬스, 인코포레이티드 위장 운동 장애의 치료에 유용한 조성물
KR20060099524A (ko) * 2003-11-03 2006-09-19 아스트라제네카 아베 무증상 위식도 역류의 치료를 위한 이미다조[1,2-ａ]피리딘유도체
US20070010543A1 (en) * 2005-07-01 2007-01-11 Dynogen Pharmaceuticals, Inc. Compositions and methods for treating gastrointestinal hypomotility and associated disorders
WO2008011016A2 (en) * 2006-07-18 2008-01-24 Dynogen Pharmaceuticals, Inc. Treating gastroesophageal reflux disease with 5-ht3- and gaba receptor agonists
BR112013020641B1 (pt) * 2011-02-25 2021-11-03 Yuhan Corporation Composto, composição farmacêutica, processos para a preparação de composto e respectivo uso ou de seu sal farmaceuticamente aceitável
WO2020185857A1 (en) * 2019-03-12 2020-09-17 The Board Of Regents Of The University Of Texas System Simultaneous blood glucose monitoring and gastric emptying scintigraphy

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05310747A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp チエノ〔３，２−ｂ〕ピリジン誘導体
WO1999063940A2 (en) * 1998-06-08 1999-12-16 Advanced Medicine, Inc. INHIBITORS OF H+K+-ATPase
JP2002526499A (ja) * 1998-09-23 2002-08-20 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング テトラヒドロピリドエーテル
WO2002064118A1 (en) * 2001-02-13 2002-08-22 Astrazeneca Ab Novel modified release formulation
JP2002538104A (ja) * 1999-03-02 2002-11-12 セプラコア インコーポレーテッド プロトンポンプ阻害剤およびｈ２受容体アンタゴニストと組み合わせて、（−）ノルシサプリドを用いた方法および組成物
JP3354132B2 (ja) * 1999-06-15 2002-12-09 三共株式会社 光学活性なピロロピリダジン化合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220011A3 (en) * 1985-10-12 1990-01-03 Beecham Group Plc Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
IE903747A1 (en) * 1989-10-19 1991-04-24 Searle & Co Method of treating gastrointestinal motility disorders
US5260303A (en) * 1991-03-07 1993-11-09 G. D. Searle & Co. Imidazopyridines as serotonergic 5-HT3 antagonists
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
ES2109190B1 (es) * 1996-03-22 1998-07-01 Univ Madrid Complutense Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht
TR200100431T2 (tr) * 1998-08-10 2001-06-21 Partnership Of Michael E. Garst, George Sachs & Jai Moo Proton pompalama önleyici ilaçlar
US6353005B1 (en) * 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease
JP4584534B2 (ja) * 2000-06-07 2010-11-24 アリックス セラピューティクス 胃食道逆流性疾患の治療のための材料
SE0101379D0 (sv) * 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
MXPA03011096A (es) * 2001-05-29 2004-12-06 Depomed Dev Ltd Metodo para el tratamiento de la enfermedad de reflujo gastroesofagico y la saturacion acida nocturna.
EP1829543B1 (en) * 2001-08-24 2009-01-21 Mitsubishi Tanabe Pharma Corporation Preventive agent/remedial agent for constipation predominant IBS
US20060281682A1 (en) * 2003-01-28 2006-12-14 Currie Mark G Methods and compositions for the treatment of gastrointestinal disorders
WO2004105795A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
KR20060118421A (ko) * 2003-08-29 2006-11-23 다이노젠 파마세우티컬스, 인코포레이티드 위장 운동 장애의 치료에 유용한 조성물

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05310747A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp チエノ〔３，２−ｂ〕ピリジン誘導体
WO1999063940A2 (en) * 1998-06-08 1999-12-16 Advanced Medicine, Inc. INHIBITORS OF H+K+-ATPase
JP2002526499A (ja) * 1998-09-23 2002-08-20 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング テトラヒドロピリドエーテル
JP2002538104A (ja) * 1999-03-02 2002-11-12 セプラコア インコーポレーテッド プロトンポンプ阻害剤およびｈ２受容体アンタゴニストと組み合わせて、（−）ノルシサプリドを用いた方法および組成物
JP3354132B2 (ja) * 1999-06-15 2002-12-09 三共株式会社 光学活性なピロロピリダジン化合物
WO2002064118A1 (en) * 2001-02-13 2002-08-22 Astrazeneca Ab Novel modified release formulation

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010529125A (ja) * 2007-06-07 2010-08-26 ダイノジェン ファーマシューティカルズ， インコーポレイテッド 胃食道逆流疾患の治療に有用な組成物
JP2013144719A (ja) * 2009-07-09 2013-07-25 Raqualia Pharma Inc 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
US8648080B2 (en) 2009-07-09 2014-02-11 Raqualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
JP5802898B2 (ja) * 2009-07-09 2015-11-04 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤

Also Published As

Publication number Publication date
WO2005021040A3 (en) 2008-01-03
AU2009236019A1 (en) 2009-12-03
IL173835A0 (en) 2006-07-05
BRPI0414046A (pt) 2006-10-24
AU2009236019B2 (en) 2011-07-07
CA2537182A1 (en) 2005-03-10
US20090048287A1 (en) 2009-02-19
AU2004268641A1 (en) 2005-03-10
MXPA06002139A (es) 2006-05-31
WO2005021040A2 (en) 2005-03-10
AU2009236019B9 (en) 2011-08-25
US20050059704A1 (en) 2005-03-17
US20060189648A1 (en) 2006-08-24
KR20060118421A (ko) 2006-11-23
EP1663313A2 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
AU2009236019B2 (en) Compositions useful for treating gastrointestinal motility disorders
ES2388501T3 (es) Uso de secretagogos de la hormona de crecimiento para estimular la motilidad del sistema gastrointestinal
AU778869B2 (en) Pharmaceutical combinations and their use in treating gastrointestinal disorders
US20060241134A1 (en) Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
JP2012509891A (ja) 肥満症及び糖尿病を治療するための胆汁酸再循環阻害剤
HUP0302476A2 (hu) Acetilkolinészteráz inhibitorok és GABAA inverz agonisták együttes alkalmazása értelmi rendellenességek kezelésére és gyógyszerkészítmények előállítására
KR20070041561A (ko) 오심 및 구토의 치료에서의 치환된2-티오-3,5-디시아노-4-페닐-6-아미노피리딘의 용도
WO2008011016A2 (en) Treating gastroesophageal reflux disease with 5-ht3- and gaba receptor agonists
US20100247584A1 (en) Compositions useful for treating gastroesophageal reflux disease
TWI564007B (zh) 作為促進劑之５－ｈｔ４受體激動劑
EP2203055A1 (en) 1-methyl nicotinamide and derivatives for treatment of gastric injury
CN104302293B (zh) 用于压力性尿失禁的预防剂和/或治疗剂
ZA200602317B (en) Composition useful for treating gastrointestinal motility disorders
JP5935863B2 (ja) 胃食道逆流症に対する薬剤
WO2006052626A2 (en) Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders
US7608625B2 (en) Method for treating bruxism and bruxism-related diseases
WO2008100422A1 (en) Compositions comprising mkc-733 (pumosetrag) useful for treating irritable bowel syndrome

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070823

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070823

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101207

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110304

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110311

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110401

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110408

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110506

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110607

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110715